Skip to main content

RxSight Inc

For the period ended Dec 31, 2024. Filed Feb 25, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 25, 2025

RXST$4.540.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

December 31,December 31,
20242023
Assets
Current assets:
Cash and cash equivalents$16,706$9,692
Short-term investments220,517117,490
Accounts receivable30,05020,281
Inventories, net22,00917,421
Prepaid and other current assets4,5413,523
Total current assets293,823168,407
Property and equipment, net12,41310,841
Operating leases right-of-use assets11,2172,444
Restricted cash750711
Other assets360147
Total assets$318,563$182,550
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$4,544$3,863
Accrued expenses and other current liabilities20,35815,239
Lease liabilities9741,801
Total current liabilities25,87620,903
Long-term lease liabilities11,3221,211
Other long-term liabilities12774
Total liabilities37,32522,188
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock, $0.001 par value, 900,000,000 shares authorized, 40,428,220 shares issued and outstanding as of December 31, 2024 and 36,139,513 shares issued and outstanding as of December 31, 20234036
Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding——
Additional paid-in capital903,127754,971
Accumulated other comprehensive loss166(5)
Accumulated deficit(622,095)(594,640)
Total stockholders' equity281,238160,362
Total liabilities and stockholders' equity$318,563$182,550
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.